Staar Surgical Co (STAA) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Staar Surgical Co  (NASDAQ: STAA)
 

Staar Surgical Co Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Staar Surgical Co inventory turnover ratio, the Staar Surgical Co's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 1.53 in the second quarter 2026, yet the ratio remained below the average, as STAA's market remain challenging.Average inventory processing period, for the Staar Surgical Co in Jul 03 2026 quarter, has decreased to 239 days, compare to 287 days, in the Apr 03 2026 quarter.

Within Healthcare sector 258 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1421 in the first quarter 2026, to 1770.

STAA Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Staar Surgical Co Market Share?

What is Inventory Turnover Ratio?




STAA Inventory Turnover Ratio (Jul 03 2026)
II. Quarter
(Apr 03 2026)
I. Quarter
(Jan 02 2026)
IV. Quarter
(Sep 26 2025)
III. Quarter
(Jun 27 2025)
II. Quarter
Y / Y Inventory Growth -6.73 % 3.41 % 28.15 % 32.06 % 35.19 %
Y / Y Cost of Sales Growth 106.65 % 69.11 % -18.74 % -16.15 % -44.05 %
Inventory Turnover Ratio (TTM) 1.53 1.27 1.09 1.22 1.37
STAA's Total Ranking # 1770 # 1421 # 1209 # 1120 # 1547
Average inventory processing period 239 288 336 300 266
Seq. Inventory Growth -0.51 % -10.29 % 4.12 % 0.37 % 10.31 %
Seq. Cost of Sales Growth -3.47 % 75.41 % -16.59 % 46.32 % -21 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 117
Healthcare Sector # 259
Overall Market # 1770

Inventory Turnover Ratio Statistics
High Average Low
3.31 2.01 0.93
(Jul 01 2022)   (Oct 03 2013)




Financial Statements
Staar Surgical Co's Inventories $ 50 Millions Visit STAA's Balance sheet
Staar Surgical Co's Cost of Revenues TTM $ 79 Millions Visit STAA's Income Statement
What are STAA's Sales? Visit STAA's Sales by Segment

Other Inventory Turnover Ratios
Staar Surgical Co's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
STAA's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for STAA's Competitors
Inventory Turnover Ratio for STAA's Suppliers
Inventory Turnover Ratio for STAA's Customers

You may also want to know
STAA's Sales Growth Rates STAA's Pe Price to earnings ratio STAA's Receivables Turnover Ratio STAA's Stock Quote
STAA's Net Income Growth Rates STAA's Ps Price to Sales ratio STAA's Sales per Employee STAA's Asset Turnover Ratio
STAA's Net Margin STAA's Pb Price to Book ratio STAA's Financial Strength Ratios STAA's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jul 03 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jul 03 2026 Inventories at quarter ending Jul 03 2026
Cryoport inc   4.40 $ 98.679  Millions$ 22  Millions
Envista Holdings Corporation  4.37 $ 1,278.500  Millions$ 293  Millions
Vericel Corporation  4.30 $ 77.922  Millions$ 18  Millions
Myomo Inc   4.23 $ 14.262  Millions$ 3  Millions
Adc Therapeutics Sa  4.17 $ 5.806  Millions$ 1  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
Alpha Teknova Inc   4.08 $ 28.288  Millions$ 7  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Coherus Oncology inc   4.03 $ 15.822  Millions$ 4  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions
Novocure Limited  4.02 $ 166.921  Millions$ 41  Millions
Koru Medical Systems Inc   3.97 $ 16.948  Millions$ 4  Millions
Elite Pharmaceuticals Inc   3.95 $ 78.824  Millions$ 20  Millions
Escalon Medical Corp   3.94 $ 7.167  Millions$ 2  Millions
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions
Sonoma Pharmaceuticals Inc   3.83 $ 13.392  Millions$ 3  Millions
Intelligent Bio Solutions Inc   3.80 $ 2.165  Millions$ 1  Millions
Iridex Corp  3.80 $ 32.517  Millions$ 9  Millions
Biocryst Pharmaceuticals Inc   3.69 $ 20.926  Millions$ 6  Millions
Abbvie Inc   3.66 $ 18,365.000  Millions$ 5,016  Millions
Teva Pharmaceutical Industries Limited  3.66 $ 8,232.000  Millions$ 2,250  Millions
Neuraxis Inc   3.55 $ 0.783  Millions$ 0  Millions
Beyond Air Inc   3.51 $ 6.447  Millions$ 2  Millions
Nexgel Inc   3.49 $ 7.577  Millions$ 2  Millions
Lifeward ltd   3.47 $ 13.976  Millions$ 4  Millions
Tandem Diabetes Care Inc   3.46 $ 456.703  Millions$ 132  Millions
Baxter International Inc   3.46 $ 8,020.000  Millions$ 2,317  Millions
Mirum Pharmaceuticals Inc   3.40 $ 85.221  Millions$ 25  Millions

Date modified: 2026-10-05T11:03:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.